Prognostic significance of estrogen receptor status in de novo metastatic breast cancer

被引：0
|
作者：
Ren Chongxi [1 ]
Sun Jianna [1 ]
Kong Lingjun [1 ]
Luo Ruizhen [1 ]
Mu Kun [1 ]
Jiang Xiuzhen [1 ]
机构：
[1] Hebei Med Univ, Cangzhou Clin Coll Integrated Tradit Chinese & We, Cangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13049
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The significance of estrogen receptor status of metastatic lesions on survival in breast cancer patients.
    Bradley, DA
    Glass, EL
    Heffelfinger, S
    Blau, R
    Lower, EE
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S57 - S57
  • [2] Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
    Barcenas, Carlos H.
    Song, Juhee
    Murthy, Rashmi K.
    Raghavendra, Akshara S.
    Li, Yisheng
    Hsu, Limin
    Carlson, Robert W.
    Tripathy, Debu
    Hortobagyi, Gabriel N.
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 789 - 804
  • [3] Prognostic Significance of pAKT Plus Estrogen Receptor Status in Adjuvant Cytotoxic Treatment of Breast Cancer
    Yang, S. X.
    Kidwell, K.
    Costantino, J. C.
    Mamounas, E. P.
    Nguyen, D.
    Kim, C.
    Wolmark, N.
    Paik, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 148 - 148
  • [4] SIGNIFICANCE OF ESTROGEN AND PROGESTERONE RECEPTOR STATUS IN PROGNOSIS OF BREAST CANCER
    Dosi, Shilpi
    Saxena, Ratna
    Nath, Dwijedra
    Singh, Mayank
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (22): : 6011 - 6017
  • [5] THE PROGNOSTIC SIGNIFICANCE OF RECEPTOR STATUS IN PATIENTS WITH EARLY BREAST CANCER
    Kolyadina, I. V.
    Poddubnaya, I. V.
    Frank, G. A.
    Komov, D. V.
    Ozhereliev, A. S.
    Karseladze, A. I.
    Ermilova, V. D.
    Vishnevskaya, Y. V.
    Makarenko, N. P.
    Kerimov, R. A.
    Teterin, K. A.
    Banov, S. M.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2012, (04) : 48 - 53
  • [6] The prognostic significance of discordant receptor results and the progesterone receptor in metastatic breast cancer
    Stuart-Harris, R.
    Shadbolt, B.
    Ross, H. A. Chaudri
    EJC SUPPLEMENTS, 2008, 6 (07): : 171 - 171
  • [7] Young age as a good prognostic factor in de novo metastatic breast cancer
    Lee, G. E.
    Dawood, S.
    Haaland, B. A.
    Tan, P. S.
    Bhoo-Pathy, N.
    Dent, R. A.
    CANCER RESEARCH, 2013, 73
  • [8] Restaging de novo metastatic breast cancer to refine prognostic estimates.
    Plichta, Jennifer Kay
    Thomas, Samantha M.
    Sergesketter, Amanda R.
    Fayanju, Oluwadamilola Motunrayo
    Greenup, Rachel Adams
    Rosenberger, Laura Horst
    Kimmick, Gretchen Genevieve
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer
    Plichta, Jennifer K.
    Thomas, Samantha M.
    Hayes, Daniel F.
    Chavez-MacGregor, Mariana
    Allison, Kimberly
    de los Santos, Jennifer
    Fowler, Amy M.
    Giuliano, Armando E.
    Sharma, Priyanka
    Smith, Benjamin D.
    van Eycken, Elizabeth
    Edge, Stephen B.
    Hortobagyi, Gabriel N.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14) : 2546 - +
  • [10] Prognostic Factors and Their Impact on Survival in Patients with De Novo Metastatic Breast Cancer
    Erdis, Eda
    Yilmaz, Mukaddes
    Ucar, Mahmut
    Yucel, Birsen
    Karadayi, Kursat
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2025, 35 (01): : 41 - 50
12345